{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:20:11Z","timestamp":1778566811282,"version":"3.51.4"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2018.00405","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T23:44:57Z","timestamp":1547682297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Transcriptomic Abnormalities in Epstein Barr Virus Associated T\/NK Lymphoproliferative Disorders"],"prefix":"10.3389","volume":"6","author":[{"given":"Sanjay","family":"de Mel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua Zhi-Chien","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand D.","family":"Jeyasekharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wee-Joo","family":"Chng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siok-Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"B1","first-page":"355","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood","author":"Quintanilla-Martinez","year":"2017","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"B2","first-page":"368","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2017","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"B3","first-page":"565","article-title":"Virally associated T-cell and NK-cell Neoplasms","volume-title":"Hematopathology","author":"Ko","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/PAP.0b013e3181916029","article-title":"Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist","volume":"16","author":"Ng","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.beha.2013.04.006","article-title":"Molecular underpinning of extranodal NK\/T-cell lymphoma","volume":"26","author":"Huang","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/ijms19071931","article-title":"The genomics and molecular biology of natural killer\/T-Cell lymphoma: opportunities for translation","volume":"19","author":"de","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12308-012-0169-1","article-title":"EBV-associated T and NK cell lymphoproliferative disorders: consensus report of the 4th Asian Hematopathology Workshop","volume":"5","author":"Ko","year":"2012","journal-title":"J Hematopathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-2559.2010.03708.x","article-title":"Impact of gene expression profiling in lymphoma diagnosis and prognosis","volume":"58","author":"Orsborne","year":"2011","journal-title":"Histopathology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.blre.2015.08.003","article-title":"Genomic signatures in T-cell lymphoma: how can these improve precision in diagnosis and inform prognosis?","volume":"30","author":"Iqbal","year":"2016","journal-title":"Blood Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/leu.2010.255","article-title":"Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro","volume":"25","author":"Iqbal","year":"2011","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/path.2823","article-title":"Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling","volume":"223","author":"Ng","year":"2011","journal-title":"J Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/leu.2009.91","article-title":"STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma","volume":"23","author":"Coppo","year":"2009","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1038\/leu.2017.40","article-title":"RUNX3 is oncogenic in natural killer\/T-cell lymphoma and is transcriptionally regulated by MY","volume":"31","author":"Selvarajan","year":"2017","journal-title":"Leukemia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1182\/blood-2012-08-450494","article-title":"EZH2 overexpression in natural killer\/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity","volume":"121","author":"Yan","year":"2013","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2016-01-690701","article-title":"EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer\/T-cell lymphoma","volume":"128","author":"Yan","year":"2016","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41375-017-0004-x","article-title":"Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer\/T-cell lymphoma","volume":"32","author":"Nairismagi","year":"2018","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3109\/10428194.2014.983099","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer\/T-cell lymphoma but shows distinctive stem cell-like phenotype","volume":"56","author":"Ng","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","article-title":"Aberrant NF-\u03baB signaling in lymphoma: mechanisms, consequences, and therapeutic implications","volume":"109","author":"Jost","year":"2007","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/jjco\/hyp037","article-title":"NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK\/T-cell lymphoma, nasal type","volume":"39","author":"Liu","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1182\/blood-2008-12-194290","article-title":"Aurora kinase A is a target of Wnt\/beta-catenin involved in multiple myeloma disease progression","volume":"114","author":"Dutta-Simmons","year":"2009","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1158\/0008-5472.CAN-03-2907","article-title":"Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.micinf.2014.04.004","article-title":"PCR array analysis of gene expression profiles in chronic active Epstein-Barr virus infection","volume":"16","author":"Murakami","year":"2014","journal-title":"Microbes Infect"},{"key":"B32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2009.11.021","article-title":"Gene modulation and immunoregulatory roles of interferon gamma","volume":"50","author":"Saha","year":"2010","journal-title":"Cytokine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.bjc.6602968","article-title":"Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK\/T-cell lymphoma and chronic active EBV infection","volume":"94","author":"Zhang","year":"2006","journal-title":"Br J Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10495-018-1440-4","article-title":"Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies","volume":"23","author":"Razaghi","year":"2018","journal-title":"Apoptosis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"p53 Mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease","volume":"159","author":"Quintanilla-Martinez","year":"2001","journal-title":"Am J Pathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","author":"Marechal","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1349-7006.2006.00226.x","article-title":"Alterations in ATR in nasal NK\/T-cell lymphoma and chronic active Epstein-Barr virus infection","volume":"97","author":"Liu","year":"2006","journal-title":"Cancer Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fonc.2018.00139","article-title":"Novel immunotherapy options for extranodal NK\/T-Cell Lymphoma","volume":"8","author":"Hu","year":"2018","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7549","DOI":"10.1200\/JCO.2017.35.15","article-title":"Oncogenic activation of STAT3 pathway drives PD-L1 expression in natural killer\/T cell lymphoma","volume":"35","author":"Lim","year":"2017","journal-title":"J Clin Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00277-015-2359-2","article-title":"CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK\/T cell lymphoma, nasal type","volume":"94","author":"Wang","year":"2015","journal-title":"Ann Hematol"},{"key":"B44","first-page":"2814","article-title":"Daratumumab efficiently targets NK\/T cell lymphoma with high CD38 expression","volume":"130","author":"Mustafa","year":"2017","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"17775","DOI":"10.1038\/s41598-017-18195-z","article-title":"Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection","volume":"7","author":"Zhong","year":"2017","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1080\/10428190903156729","article-title":"Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas","volume":"50","author":"J\u00f8rgensen","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"B50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1086\/527330","article-title":"Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection","volume":"197","author":"Ito","year":"2008","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jmv.20197","article-title":"Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection","volume":"74","author":"Ohga","year":"2004","journal-title":"J Med Virol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/cam4.256","article-title":"Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T\/NK-cell proliferation","volume":"3","author":"Ito","year":"2014","journal-title":"Cancer Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.clml.2014.01.007","article-title":"Status of PI3K\/Akt\/mTOR pathway inhibitors in lymphoma","volume":"14","author":"Westin","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/path.2789","article-title":"Notch signalling in T-cell lymphoblastic leukaemia\/lymphoma and other haematological malignancies","volume":"223","author":"Aster","year":"2011","journal-title":"J Pathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.12045","article-title":"MicroRNA function in NK-cell biology","volume":"253","author":"Beaulieu","year":"2013","journal-title":"Immunol Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/ped.12314","article-title":"Current research on chronic active Epstein-Barr virus infection in Japan","volume":"56","author":"Fujiwara","year":"2014","journal-title":"Pediatr Int"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1182\/blood-2011-07-364224","article-title":"Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer\/T-cell lymphoma","volume":"118","author":"Ng","year":"2011","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042193","article-title":"MicroRNA profiling of Epstein-Barr virus-associated NK\/T-cell lymphomas by deep sequencing","author":"Motsch","year":"2012","journal-title":"PLoS ONE"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1182\/blood-2009-06-222794","article-title":"Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma\/leukemia","volume":"114","author":"Yamanaka","year":"2009","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1158\/1078-0432.CCR-11-0494","article-title":"MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK\/T cell lymphoma","volume":"17","author":"Paik","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1155\/2010\/474692","article-title":"Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer\/T-cell lymphoma","volume":"29","author":"Guo","year":"2010","journal-title":"Dis Markers"},{"key":"B62","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/infdis\/jit222","article-title":"Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection","volume":"208","author":"Kawano","year":"2013","journal-title":"J Infect Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajh.21247","article-title":"Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan","volume":"83","author":"Sato","year":"2008","journal-title":"Am J Hematol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13023-014-0165-x","article-title":"Prognostic implication of morphology, cyclinE2, and proliferation in EBV-associated T\/NK lymphoproliferative disease in non-immunocompromised hosts","volume":"9","author":"Ng","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","article-title":"Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis","volume":"2","author":"Kim","year":"2015","journal-title":"Lancet Haematol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","article-title":"Targeting CD38 with daratumumab monotherapy in multiple myeloma","volume":"373","author":"Lokhorst","year":"2015","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJMc1605684","article-title":"Targeting CD38 in refractory extranodal natural killer cell-T-cell lymphoma","volume":"375","author":"Hari","year":"2016","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ajpath.2017.01.004","article-title":"Novel JAK3-activating mutations in extranodal NK\/T-cell lymphoma, nasal type","volume":"187","author":"Sim","year":"2017","journal-title":"Am J Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-016-0267-0","article-title":"Therapeutic options in peripheral T cell lymphoma","volume":"9","author":"Zhang","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B74","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1182\/blood.V128.22.5353.5353","article-title":"A phase II study of Bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in patients with newly diagnosed natural-killer\/T-cell lymphoma","volume":"128","author":"Tang","year":"2016","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3892\/mco.2017.1364","article-title":"Treatment of relapsed extranodal natural killer\/T-cell lymphoma with bortezomib plus fludarabine","volume":"7","author":"Chen","year":"2017","journal-title":"Mol Clin Oncol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00405\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T10:40:48Z","timestamp":1573728048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00405\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":75,"alternative-id":["10.3389\/fped.2018.00405"],"URL":"https:\/\/doi.org\/10.3389\/fped.2018.00405","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"article-number":"405"}}